Benchmark Holdings plc (BHCCF)
BHCCF Stock Price Chart
Explore Benchmark Holdings plc interactive price chart. Choose custom timeframes to analyze BHCCF price movements and trends.
BHCCF Company Profile
Discover essential business fundamentals and corporate details for Benchmark Holdings plc (BHCCF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
19 Jun 2018
Employees
800.00
Website
https://www.benchmarkplc.comCEO
Trond Williksen
Description
Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass/bream, salmon, shrimp, and tilapia breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and CleanTreat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was founded in 2000 and is headquartered in Sheffield, the United Kingdom.
BHCCF Financial Timeline
Browse a chronological timeline of Benchmark Holdings plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 26 Feb 2026
Upcoming earnings on 27 Nov 2025
Earnings released on 12 Jun 2025
EPS came in at -$0.01 falling short of the estimated -$0.00 by -779.31%, while revenue for the quarter reached $29.58M , beating expectations by +4.11%.
Earnings released on 29 May 2025
EPS came in at $0.15 , while revenue for the quarter reached $29.57M , beating expectations by +36.48%.
Earnings released on 28 Feb 2025
EPS came in at -$0.02 falling short of the estimated $0.00 by -596.45%, while revenue for the quarter reached $22.17M , missing expectations by -7.61%.
Earnings released on 27 Nov 2024
EPS came in at -$0.04 falling short of the estimated $0.00 by -3.64K%, while revenue for the quarter reached -$26.93M , missing expectations by -147.72%.
Earnings released on 22 Aug 2024
EPS came in at -$0.02 falling short of the estimated $0.00 by -2.33K%, while revenue for the quarter reached $38.84M , missing expectations by -16.96%.
Earnings released on 22 May 2024
EPS came in at -$0.00 falling short of the estimated $0.01 by -140.36%, while revenue for the quarter reached $49.89M , missing expectations by -14.08%.
Earnings released on 15 Feb 2024
EPS came in at -$0.01 falling short of the estimated $0.00 by -384.72%, while revenue for the quarter reached $51.16M , missing expectations by -18.26%.
Earnings released on 30 Sept 2023
EPS came in at -$0.02 falling short of the estimated -$0.01 by -175.91%, while revenue for the quarter reached $44.21M , missing expectations by -13.26%.
Earnings released on 30 Jun 2023
EPS came in at -$0.01 falling short of the estimated -$0.00 by -1.86K%, while revenue for the quarter reached $43.39M , missing expectations by -12.52%.
Earnings released on 31 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $54.84M , beating expectations by +1.92%.
Earnings released on 31 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $66.98M , beating expectations by +30.31%.
Earnings released on 30 Sept 2022
EPS came in at -$0.02 , while revenue for the quarter reached $47.31M , beating expectations by +0.93%.
Earnings released on 30 Jun 2022
EPS came in at -$0.02 , while revenue for the quarter reached $44.03M , beating expectations by +4.86%.
Earnings released on 31 Mar 2022
EPS came in at -$0.01 , while revenue for the quarter reached $51.46M .
Earnings released on 31 Dec 2021
EPS came in at -$0.01 , while revenue for the quarter reached $53.98M .
Earnings released on 30 Sept 2021
EPS came in at -$0.01 , while revenue for the quarter reached $50.33M , beating expectations by +5.78%.
Earnings released on 30 Jun 2021
EPS came in at -$0.01 , while revenue for the quarter reached $39.15M .
Earnings released on 31 Mar 2021
EPS came in at -$0.01 , while revenue for the quarter reached $42.05M .
Earnings released on 31 Dec 2020
EPS came in at -$0.00 , while revenue for the quarter reached $39.49M .
Earnings released on 30 Sept 2020
EPS came in at -$0.02 , while revenue for the quarter reached $32.57M .
BHCCF Stock Performance
Access detailed BHCCF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.